Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.70 Min. order: 1 piece ★★★★★ 4.8 (196 reviews) Sold : Login>>
Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports US$ 23.60 Min. order: 1 piece ★★★★★ 4.4 (282 reviews) Sold : Login>>
GHK-Cu (Copper Peptide) Therapy in South Florida – Prescription Consultation & Medical Evaluation US$ 26.03 Min. order: 1 piece ★★★★★ 4.8 (13 reviews) Sold : Login>>
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management - Alhomoud - 2024 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy US$ 22.92 Min. order: 1 piece ★★★★★ 4.7 (178 reviews) Sold : Login>>
Incretin-based therapies for the treatment of obesity-related diseases US$ 27.73 Min. order: 1 piece ★★★★★ 4.6 (294 reviews) Sold : Login>>